Inventurus Knowledge Solutions Ltd
NSE:IKS
Inventurus Knowledge Solutions Ltd
Inventurus Knowledge Solutions Ltd is a IN-based company operating in Health Care Technology industry. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 12,405 full-time employees. The company went IPO on 2024-12-19. Inventurus Knowledge Solutions Limited is an India-based company. The firm is a technology-enabled healthcare solutions provider and offers a care enablement platform assisting physician enterprises in the United States, Canada and Australia, with a focus on the United States market. The company offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Its technology solutions include IKS EVE, Optimix, IKS Stacks, IKS AssuRx, Dashboard, and IKS Scribble. IKS EVE is its multichannel patient access and patient engagement solution. Optimix is its proprietary workflow management platform for revenue optimization. IKS Stacks scans, identifies and abstracts relevant data from incoming clinical documents. In addition, it also uses robotic process automation (RPA) to help automate structured and repetitive processes in virtual desktop/ application environments. Its other platforms include QTranscribe/Medico-Legal, QDocprep, QScribe Assist, and QCode.
Inventurus Knowledge Solutions Ltd is a IN-based company operating in Health Care Technology industry. The company is headquartered in Navi Mumbai, Maharashtra and currently employs 12,405 full-time employees. The company went IPO on 2024-12-19. Inventurus Knowledge Solutions Limited is an India-based company. The firm is a technology-enabled healthcare solutions provider and offers a care enablement platform assisting physician enterprises in the United States, Canada and Australia, with a focus on the United States market. The company offers a comprehensive platform that enables healthcare enterprises across outpatient and inpatient care. Its technology solutions include IKS EVE, Optimix, IKS Stacks, IKS AssuRx, Dashboard, and IKS Scribble. IKS EVE is its multichannel patient access and patient engagement solution. Optimix is its proprietary workflow management platform for revenue optimization. IKS Stacks scans, identifies and abstracts relevant data from incoming clinical documents. In addition, it also uses robotic process automation (RPA) to help automate structured and repetitive processes in virtual desktop/ application environments. Its other platforms include QTranscribe/Medico-Legal, QDocprep, QScribe Assist, and QCode.
Revenue Growth: IKS Health reported Q4 FY25 revenue of INR 724 crores, up 17% year-on-year, and full-year revenue of INR 2,664 crores, a 47% increase.
Profitability Surge: Q4 EBITDA was INR 226 crores, up 68% YoY, with PAT rising 133%. Full-year EBITDA was INR 791 crores (up nearly 50%) and PAT reached INR 486 crores (+31.2% YoY).
Margin Expansion: Q4 EBITDA margin rose to over 31%, significantly up from 24% pro forma in FY24, driven by AQuity integration, tech adoption, and cost synergies.
AI & Tech Progress: Major progress in shifting from human-led to tech-led and autonomous GenAI processes, boosting scalability and margins.
Strong Cash Flow & Debt Reduction: Operating cash flow was INR 434 crores, free cash flow INR 275 crores, and net debt reduced to INR 560 crores from INR 860 crores.
New Wins & Cross-Sell: Secured notable deals with Sky Lakes, Western Washington, Platinum Derm, Ortho New York, and GI Alliance; early success in cross-selling IKS features to AQuity's client base.
No Forward Guidance: Management does not provide specific future guidance due to market immaturity but expects to outpace the 12% growth in outsourced TAM.
